These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7812856)

  • 21. [High frequency ventilation by oscillation in the treatment of the hyaline membrane disease in severe form].
    Cortambert F; Putet G; Salle B; Deiber M
    Arch Fr Pediatr; 1988 Apr; 45(4):243-7. PubMed ID: 3136752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency ventilation (HFV) in hyaline membrane disease--a preliminary report.
    Pfenninger J; Gerber AC
    Intensive Care Med; 1987; 13(1):71-5. PubMed ID: 3558939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analyses of surfactant replacement therapy of infants with birth weights less than 2000 grams.
    Kresch MJ; Clive JM
    J Perinatol; 1998; 18(4):276-83. PubMed ID: 9730197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High frequency oscillatory ventilation in pediatrics].
    Laubscher B
    Rev Med Suisse Romande; 1996 Dec; 116(12):975-8. PubMed ID: 9026887
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bronchopulmonary dysplasia after artificial ventilation of newborns (author's transl)].
    Marcovich M; Pollauf F; Rosenkranz A
    Padiatr Padol; 1982; 17(2):361-70. PubMed ID: 7048204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assisted ventilation for hyaline membrane disease.
    Singh M; Deorari AK; Aggarwal R; Paul VK
    Indian Pediatr; 1995 Dec; 32(12):1267-74. PubMed ID: 8772883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotracheal continuous positive airway pressure after rescue surfactant therapy.
    Mandy GT; Moïse AA; Smith EO; Hansen TN
    J Perinatol; 1998; 18(6 Pt 1):444-8. PubMed ID: 9848758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of surfactant, lung compliance, and aeration of preterm rabbit lungs after surfactant therapy and conventional and high-frequency oscillatory ventilation.
    Heldt GP; Merritt TA; Golembeski D; Gilliard N; Bloor C; Spragg R
    Pediatr Res; 1992 Mar; 31(3):270-5. PubMed ID: 1561014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
    Helbich TH; Popow C; Dobner M; Wunderbaldinger P; Zekert M; Herold CJ
    Eur J Radiol; 1998 Oct; 28(3):243-9. PubMed ID: 9881260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High frequency oscillatory ventilation in the preterm newborn infants with respiratory distress syndrome].
    Tejera Ramírez C; Siles Quesada C; Reyes Suárez D; González Azpeitia G; Gresa M; Martínez Sopena J; Quero Jiménez J
    An Esp Pediatr; 1997 Feb; 46(2):177-82. PubMed ID: 9157809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
    Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
    Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant nebulization versus instillation during high frequency ventilation in surfactant-deficient rabbits.
    Dijk PH; Heikamp A; Oetomo SB
    Pediatr Res; 1998 Nov; 44(5):699-704. PubMed ID: 9803451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between neonatal care practices and efficacy of exogenous human surfactant: results of a bicenter randomized trial.
    Hallman M; Merritt TA; Bry K; Berry C
    Pediatrics; 1993 Mar; 91(3):552-60. PubMed ID: 8441558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.
    Cogo PE; Zimmermann LJ; Pesavento R; Sacchetto E; Burighel A; Rosso F; Badon T; Verlato G; Carnielli VP
    Crit Care Med; 2003 May; 31(5):1532-8. PubMed ID: 12771629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary dysplasia in infancy. Pathogenesis, pneumologic course studies and therapy possibilities].
    Becker B; Reinhardt D; Risselmann K; Morgenroth K; Kemperdick H; Lemburg P
    Monatsschr Kinderheilkd; 1984 Jul; 132(7):525-33. PubMed ID: 6472297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of neonates requiring assisted ventilation.
    Anantharaj A; Bhat BV
    Turk J Pediatr; 2011; 53(5):547-53. PubMed ID: 22272457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD; Hayward PE; Martell M; Del Barco M; Margotto P; Grandzoto J; Bastida J; Peña J; Villanueva D
    J Perinat Med; 1997; 25(3):280-7. PubMed ID: 9288665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxygen toxicity in the premature baboon with hyaline membrane disease.
    Delemos RA; Coalson JJ; Gerstmann DR; Kuehl TJ; Null DM
    Am Rev Respir Dis; 1987 Sep; 136(3):677-82. PubMed ID: 3307571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study].
    Sánchez-Mendiola M; Martínez-Natera OC; Herrera-Maldonado N; Ortega-Arroyo J
    Gac Med Mex; 2005; 141(4):267-71. PubMed ID: 16164120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
    Wright K
    J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.